Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement
- PMID: 3346818
- DOI: 10.1002/jps.2600770104
Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement
Abstract
Ultrastructure analysis was conducted in an effort to augment the results of classical kinetic studies. Scanning electron microscopy (SEM) allowed visual inspection of cellular junctions on corneal epithelium and endothelium. The addition of calcium-chelating agents to in vivo and in vitro mounted corneas demonstrated a concentration-dependent progressive expansion of the intercellular spaces of epithelium and endothelium, as seen by SEM. The expansion of these cellular junctions correlates with increases in permeability of the cornea to glycerol under similar conditions. The size of the intercellular space was estimated by transmission electron microscopy. Use of lanthanum as a marker of aqueous diffusional pathways demonstrated that the epithelial surface is not a totally occlusive barrier to transport of small hydrophilic compounds. Development of a method whereby an administered drug could be visualized in its actual pathway of movement through the cornea was undertaken, involving precipitation of specific compounds in the tissue with osmium tetroxide vapor. Results suggest that separate pathways of drug movement exist in the cornea for hydrophilic and hydrophobic compounds. Hydrophilic compounds were preferentially located in intercellular spaces, whereas hydrophobic compounds were associated with the lipid structures of the tissue. The results of these studies are consistent with a currently proposed 'pore' model for the penetration of drugs through the cornea.
Similar articles
-
Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.J Pharm Sci. 1988 Jan;77(1):3-14. doi: 10.1002/jps.2600770103. J Pharm Sci. 1988. PMID: 3126290
-
Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions.J Pharm Sci. 1983 Nov;72(11):1272-9. doi: 10.1002/jps.2600721109. J Pharm Sci. 1983. PMID: 6139472
-
Mechanisms of corneal drug penetration. III: Modeling of molecular transport.J Pharm Sci. 1988 Jan;77(1):24-6. doi: 10.1002/jps.2600770105. J Pharm Sci. 1988. PMID: 3346819
-
Scanning electron microscopic observations of a mucopolysaccharide coating on human corneal endothelium.Acta Ophthalmol (Copenh). 1978 Feb;56(1):161-7. doi: 10.1111/j.1755-3768.1978.tb00478.x. Acta Ophthalmol (Copenh). 1978. PMID: 147601
-
[The cornea: stasis and dynamics].Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):179-212; discussion 213. Nippon Ganka Gakkai Zasshi. 2008. PMID: 18411711 Review. Japanese.
Cited by
-
High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.Eye (Lond). 2012 Jul;26(7):1012-20. doi: 10.1038/eye.2012.89. Epub 2012 May 18. Eye (Lond). 2012. PMID: 22595911 Free PMC article.
-
[Pharmacokinetics of the anterior eye].Ophthalmologe. 2014 Feb;111(2):107-12. doi: 10.1007/s00347-013-2931-x. Ophthalmologe. 2014. PMID: 24337342 German.
-
Ocular inserts - Advancement in therapy of eye diseases.J Adv Pharm Technol Res. 2010 Jul;1(3):291-6. doi: 10.4103/0110-5558.72419. J Adv Pharm Technol Res. 2010. PMID: 22247860 Free PMC article.
-
Entrapment of ketorolac tromethamine in polymeric vehicle for controlled drug delivery.Indian J Pharm Sci. 2009 Nov;71(6):687-91. doi: 10.4103/0250-474X.59555. Indian J Pharm Sci. 2009. PMID: 20376226 Free PMC article.
-
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.Inflammation. 2000 Aug;24(4):371-84. doi: 10.1023/a:1007001131987. Inflammation. 2000. PMID: 10850858
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources